Clarapath, a medical robotics company modernizing and transforming how pathology laboratories process tissue, has raised $36 million in its Series B-1 funding round, which was led by Northwell Ventures.
Additional new strategic investors participated in the financing, including CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures, bringing the company’s total funding to $75 million.
Eric Feinstein, CEO of Clarapath, says: “Our strategic investors share in our mission to significantly overhaul this critical aspect of patient care that has long been overlooked. [Read more…] about Clarapath closes $36 million Series B investment round to ‘transform 150-year old laboratory processes’